4 directorsHidden nameVisible after signing in and 3 others
Documentsfilings and deeds
21-06-202640 days before the deadline
2025micro format
Gross margin from -€201,554 to €2.3mProfit of €267,760, after a loss3 directors appointed16-12New day-to-day manager24-10Registered office moved within Hasselt22-01Debts from €3.1m to €3.5m
Lower solvency than 95% of companies in research and development. Sector median 59.8% · 666 companies.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 823 companies had the same profile as Amador Bioscience has now. Each dot stands for 3 companies, two years later.
91.9%
were still trading
3.6%
stopped another way
2.9%
went bankrupt
Small
negative equity
a profit of 5% of the balance sheet or more
without age
Another 1.6% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 823 companies, not a prediction for Amador Bioscience. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Hidden nameVisible after signing in (director) and Name after signing inVisible after signing in (day-to-day manager) resign
General meeting of 03-07-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0779966013
3 directors appointedName hiddenVisible after signing in, Hidden nameVisible after signing in and Name after signing inVisible after signing in · General meeting of 01-12-2025 · Gazette deed
New day-to-day managerName hiddenVisible after signing in appointed, Hidden nameVisible after signing in resigned · Board meeting of 29-04-2025 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as Amador Bioscience: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €991,000 and €2.4m, founded between 2020 and 2023.
The company number of Amador Bioscience is 0779.966.013. The VAT number is the same number with BE in front: BE 0779.966.013.
Where is Amador Bioscience based?
The registered office is at Hendrik van Veldekesingel 150, 3500 Hasselt.Company details
What does Amador Bioscience do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of Amador Bioscience?
Amador Bioscience is a private limited company (BV).
When was Amador Bioscience founded?
Amador Bioscience was founded on 11-01-2022.
Is Amador Bioscience still active?
Yes, Amador Bioscience is an active enterprise in the KBO register.
How many employees does Amador Bioscience have?
Amador Bioscience had an average of 8.6 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
Which joint committee does Amador Bioscience fall under?
In its 2023 annual accounts, Amador Bioscience states joint committee 200 (Auxiliary committee for white-collar workers).
What is the turnover of Amador Bioscience?
The turnover in financial year 2025 is ≈ €4.1m. This figure is estimated from the gross margin of €2.3m and 77 comparable companies of the same size. It probably lies between €2.7m and €5.5m. It is a rough estimate.
Is Amador Bioscience profitable?
In financial year 2025, Amador Bioscience made a profit of €267,760.
Where can I find the annual accounts of Amador Bioscience?
Amador Bioscience filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Amador Bioscience due?
Amador Bioscience must file the annual accounts for financial year 2026 by 31-07-2027.Timeline